TGF beta 1/2/3 Antibody (1D11R) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # FAB1835RZ
Recombinant Monoclonal Antibody.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Multi-Species
Applications
Neutralization
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG1 Clone # 1D11R
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Bovine bone-derived TGF-beta 1 and TGF-beta 2
Specificity
Detects bovine, chicken, mouse, and human TGF-beta in ELISAs and Western blots. It recognizes human TGF-beta 1, TGF-beta 2, and TGF-beta 3.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for TGF beta 1/2/3 Antibody (1D11R) [DyLight 755]
Application
Recommended Usage
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from cell culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TGF beta 1/2/3
Long Name
Transforming Growth Factor beta 1, 2, and 3
Alternate Names
CED, DPD1, LAP, TGFB, TGFB1, TGFbeta, transforming growth factor, beta 1
Additional TGF beta 1/2/3 Products
Product Documents for TGF beta 1/2/3 Antibody (1D11R) [DyLight 755]
Product Specific Notices for TGF beta 1/2/3 Antibody (1D11R) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...